Erectile function following external beam radiotherapy for clinically organ-confined or locally advanced prostate cancer

Japanese Journal of Clinical Oncology

Volumn 34, Issue 5, 2004, Pages 269-273

  Hisasue, Shin Ichi ^a   Kato, Ryuichi ^a   Takahashi, Atsushi ^a   Masumori, Naoya ^a   Itoh, Naoki ^a   Miyao, Noriomi ^a   Takatsuka, Keiji ^b   Yanase, Masahiro ^c   Oouchi, Atsushi ^c   Hareyama, Masato ^a   Tsukamoto, Taiji ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b Muroran City General Hospital   (Japan)

^c SUNAGAWA CITY MEDICAL CENTER   (Japan)

Author keywords

Erectile dysfunction; External beam radiotherapy; Prostate cancer

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER LOCALIZATION; CONTROLLED STUDY; ERECTILE DYSFUNCTION; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONBIOLOGICAL MODEL; PREDICTION; PROSTATE CANCER; QUESTIONNAIRE; RETROSPECTIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; IMPOTENCE; MIDDLE AGED; PENIS ERECTION; PROPORTIONAL HAZARDS MODEL; PROSTATE TUMOR; RADIATION DOSE; RADIATION EXPOSURE;

AGED; AGED, 80 AND OVER; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PENILE ERECTION; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES;

EID: 3343014888     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyh041     Document Type: Article

References (24)

1. Turner SL, Adams K, Bull CA, Berry MP. Sexual dysfunction after radical radiation therapy for prostate cancer: A prospective evaluation. Urology 1999;54:124-9.
2. McCammon KA, Kolm P, Main B, Schellhammer PF. Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer. Urology 1999;54:509-16.
3. al-Abany M, Steineck G, Agren Cronqvist AK, Helgason AR. Improving the preservation of erectile function after external beam radiation therapy for prostate cancer. Radiother Oncol 2000;57:201-6.
4. Wilder RB, Chou RH, Ryu JK, Stern RL, Wong MS, Ji M. et al. Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: Preliminary results. Am J Clin Oncol 2000;23:330-3.
5. Siegel T, Moul JW, Spevak M, Alvord WG, Costabile RA. The development of erectile dysfunction in men treated for prostate cancer. J Urol 2001;165:430-5.
6. Schwartz K, Bunner S, Bearer R, Severson RK. Complications from treatment for prostate. carcinoma among men in the Detroit area. Cancer 2002; 95:82-9.
7. Schover LR, Fouladi RT, Warneke CL, Neese L, Klein EA, Zippe C, et al. Defining sexual outcomes after treatment for localized prostate carcinoma. Cancer 2002;95:1773-85.
8. Egawa S, Shimura S, Irie A, Kitano M, Nishiguchi I, Kuwao S, et al. Toxicity and health-related quality of life during and after high dose rate brachytherapy followed by external beam radiotherapy for prostate cancer. Jpn J Clin Oncol 2001;31:541-7.
9. Masumori N, Tsukamoto T, Kumamoto Y, Panser LA, Rhodes T, Girman CJ, et al. Decline of sexual function with age in Japanese men compared with American men - results of two community-based studies. Urology 1999;54:335-45.
10. Kato R, Sato Y, Horita H, Ito N, Kumamoto Y, Tsukamoto T, et al. Validity analysis of Sapporo Medical University - sexual function questionnaire. Nippon Hinyokika Gakkai Zasshi 1999;90:872-7.
11. Merrick GS, Wallner K, Butler WM, Galbreath RW, Lief JH, Benson ML. A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction. Int J Radiat Oncol Biol Phys 2001;50:597-604.
12. Zelefsky MJ, Cowen D, Fuks Z, Shike M, Burman C, Jackson A, Venkatramen ES, Leibel SA. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer 1999;85:2460-8.
13. Sobin LH, Fleming ID. TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997;80:1803-4.
14. Horwitz EM, Vicini FA, Ziaja EL, Dmuchowski CF, Stromberg IS, Martinez AA. The correlation between the ASTRO Consensus Panel definition of biochemical failure and clinical outcome for patients with prostate cancer treated with external beam irradiation. American Society of Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys 1998;41:267-72.
15. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993;270:83-90.
16. Goldstein I, Feldman MI, Deckers PJ, Babayan RK, Krane RJ. Radiation-associated impotence. A clinical study of its mechanism. JAMA 1984;251: 903-10.
17. Merlin SL, Brock GB, Begin LR, Hiou Tim FF, Macramalla AN, Seyam RM, et al. New insights into the role of endothelin-1 in radiation-associated impotence. Int J Impot Res 2001;13:104-9.
18. Zelefsky MJ, McKee AB, Lee H, Leibel SA. Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate. Urology 1999;53:775-8.
19. Weber DC, Bieri S, Kurtz JM, Miralbell R. Prospective pilot study of sildenafil for treatment of postradiotherapy erectile dysfunction in patients with prostate cancer. J Clin Oncol 1999;17:3444-9.
20. Kedia S, Zippe CD, Agarwal A, Nelson DR, Lakin MM. Treatment of erectile dysfunction with sildenafil citrate (Viagra) after radiation therapy for prostate cancer. Urology 1999;54:308-12.
21. Mulhall JP, Yonover P, Sethi A, Yasuda G, Mohideen N. Radiation exposure to the corporeal bodies during 3-dimensional conformal radiation therapy for prostate cancer. J Urol 2002;167:539-42.
22. Chinn DM, Holland J, Crownover RL, Roach M 3rd. Potency following high-dose three-dimensional conformal radiotherapy and the impact of prior major mologic surgical procedures in patients treated for prostate cancer. Int J Radiat Oncol Biol Phys 1995;33:15-22.
23. Feldman HA, Goldstein I, Hatzichristou DG, Krane R J, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61.
24. Bacon CG, Giovannucci E, Testa M, Glass TA, Kawachij. The association of treatment-related symptoms with quality-of-life outcomes for localized prostate carcinoma patients. Cancer 2002;94:862-71.